Last week, John was at the European Society of Cardiology conference in Madrid, and Adam was at the Preventing Overdiagnosis 2025 International Conference in Oxford. A conversation about what we learned.
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
Beta-Blockers Post-MI: A Clear Clinical Message
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation